Department of Spinal Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Department of Orthopedic Surgery, Changzheng Hospital, The Second Military Medical University of China, Shanghai, China.
J Cell Physiol. 2020 Jun;235(6):5305-5317. doi: 10.1002/jcp.29416. Epub 2019 Dec 25.
Although degenerative disc disease (DDD) and related low back pain (LBP) are growing public health problems, the underlying disease mechanisms remain unclear. An increase in the vascular endothelial growth factor (VEGF) levels in DDD has been reported. This study aimed to examine the role of VEGF receptors (VEGFRs) in DDD, using a mouse model of DDD. Progressive DDD was induced by anterior stabbing of lumbar intervertebral discs in wild type (WT) and VEGFR-1 tyrosine-kinase deficient mice (vegfr-1 ). Pain assessments were performed weekly for 12 weeks. Histological and immunohistochemical assessments were made for discs, dorsal root ganglions, and spinal cord. Both vegfr-1 and WT mice presented with similar pathological changes in discs with an increased expression of inflammatory cytokines and matrix-degrading enzymes. Despite the similar pathological patterns, vegfr-1 mice showed insensitivity to pain compared with WT mice. This insensitivity to discogenic pain was related to lower levels of pain factors in the discs and peripheral sensory neurons and lower spinal glial activation in the vegfr-1 / mice than in the WT mice. Exogenous stimulation of bovine disc cells with VEGF increased inflammatory and cartilage degrading enzyme. Silencing vegfr-1 by small-interfering-RNA decreased VEGF-induced expression of pain markers, while silencing vegfr-2 decreased VEGF-induced expression of inflammatory and metabolic markers without changing pain markers. This suggests the involvement of VEGFR-1 signaling specifically in pain transmission. Collectively, our results indicate that the VEGF signaling is involved in DDD. Particularly, VEGFR-1 is critical for discogenic LBP transmission independent of the degree of disc pathology.
尽管退行性椎间盘疾病(DDD)和相关的下腰痛(LBP)是日益严重的公共健康问题,但潜在的疾病机制仍不清楚。已经报道了 DDD 中血管内皮生长因子(VEGF)水平的增加。本研究旨在使用 DDD 的小鼠模型来研究 VEGF 受体(VEGFRs)在 DDD 中的作用。通过在前腰椎间盘刺伤野生型(WT)和 VEGFR-1 酪氨酸激酶缺陷型(vegfr-1)小鼠来诱导进行性 DDD。每周进行 12 周的疼痛评估。对椎间盘、背根神经节和脊髓进行组织学和免疫组织化学评估。vegfr-1 和 WT 小鼠的椎间盘均表现出相似的病理变化,炎症细胞因子和基质降解酶的表达增加。尽管存在相似的病理模式,但与 WT 小鼠相比,vegfr-1 小鼠对疼痛不敏感。这种对椎间盘源性疼痛的不敏感与椎间盘和外周感觉神经元中的疼痛因子水平较低以及脊髓胶质激活较低有关。牛椎间盘细胞用 VEGF 进行外源性刺激会增加炎症和软骨降解酶。通过小干扰 RNA 沉默 vegfr-1 可降低 VEGF 诱导的疼痛标志物的表达,而沉默 vegfr-2 可降低 VEGF 诱导的炎症和代谢标志物的表达,而不改变疼痛标志物。这表明 VEGFR-1 信号通路参与疼痛传递。总的来说,我们的结果表明 VEGF 信号通路参与了 DDD。特别是,VEGFR-1 对于椎间盘源性 LBP 传递是至关重要的,而与椎间盘病理程度无关。